GENEVA, May 12 -- NEXTGEN BIOSCIENCE CO., LTD. (3rd Floor, Elentec building, 17 Pangyo-ro 228beon-gil,Bundang-gu, Seongnam-si,Gyeonggi-do 13487), 주식회사 넥스트젠바이오사이언스 (경기도성남시 분당구판교로228번길 17, 이랜텍동 3층) filed a patent application (PCT/KR2025/017623) for "NOVEL COMPOUND AS FUNCTIONAL INHIBITOR AGAINST S1PR1 AND S1PR4" on Oct 30, 2025. With publication no. WO/2026/095688, the details related to the patent application was published on May 07, 2026.
Notably, the patent application was submitted under the Internationa...